The ethyl ascorbic acid market is projected to grow from USD 1.4 billion in 2025 to USD 2.9 billion by 2035, at a CAGR of 7.5%. Chemicals will dominate with a 31.2% market share, while pharmaceutical industry will lead the end-user segment with a 41.9% share.